Literature DB >> 21548618

Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy.

Jin Xie1, Gang Liu, Henry S Eden, Hua Ai, Xiaoyuan Chen.   

Abstract

Enormous efforts have been made toward the translation of nanotechnology into medical practice, including cancer management. Generally the applications have fallen into two categories: diagnosis and therapy. Because the targets are often the same, the development of separate approaches can miss opportunities to improve efficiency and effectiveness. The unique physical properties of nanomaterials enable them to serve as the basis for superior imaging probes to locate and report cancerous lesions and as vehicles to deliver therapeutics preferentially to those lesions. These technologies for probes and vehicles have converged in the current efforts to develop nanotheranostics, nanoplatforms with both imaging and therapeutic functionalities. These new multimodal platforms are highly versatile and valuable components of the emerging trend toward personalized medicine, which emphasizes tailoring treatments to the biology of individual patients to optimize outcomes. The close coupling of imaging and treatment within a theranostic agent and the data about the evolving course of an illness that these agents provide can facilitate informed decisions about modifications to treatment. Magnetic nanoparticles, especially superparamagnetic iron oxide nanoparticles (IONPs), have long been studied as contrast agents for magnetic resonance imaging (MRI). Owing to recent progress in synthesis and surface modification, many new avenues have opened for this class of biomaterials. Such nanoparticles are not merely tiny magnetic crystals, but potential platforms with large surface-to-volume ratios. By taking advantage of the well-developed surface chemistry of these materials, researchers can load a wide range of functionalities, such as targeting, imaging and therapeutic features, onto their surfaces. This versatility makes magnetic nanoparticles excellent scaffolds for the construction of theranostic agents, and many efforts have been launched toward this goal. In this Account, we introduce the surface engineering techniques that we and others have developed, with an emphasis on how these techniques affect the role of nanoparticles as imaging or therapeutic agents. We and others have developed a set of chemical methods to prepare magnetic nanoparticles that possess accurate sizes, shapes, compositions, magnetizations, relaxivities, and surface charges. These features, in turn, can be harnessed to adjust the toxicity and stability of the nanoparticles and, further, to load functionalities, via various mechanisms, onto the nanoparticle surfaces.

Entities:  

Mesh:

Year:  2011        PMID: 21548618      PMCID: PMC3166427          DOI: 10.1021/ar200044b

Source DB:  PubMed          Journal:  Acc Chem Res        ISSN: 0001-4842            Impact factor:   22.384


  47 in total

1.  Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro.

Authors:  Forrest M Kievit; Freddy Y Wang; Chen Fang; Hyejung Mok; Kui Wang; John R Silber; Richard G Ellenbogen; Miqin Zhang
Journal:  J Control Release       Date:  2011-01-26       Impact factor: 9.776

2.  Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles.

Authors:  Hyon Bin Na; Jung Hee Lee; Kwangjin An; Yong Il Park; Mihyun Park; In Su Lee; Do-Hyun Nam; Sung Tae Kim; Seung-Hoon Kim; Sang-Wook Kim; Keun-Ho Lim; Ki-Soo Kim; Sun-Ok Kim; Taeghwan Hyeon
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

Review 3.  Dual-modality probes for in vivo molecular imaging.

Authors:  Seulki Lee; Xiaoyuan Chen
Journal:  Mol Imaging       Date:  2009 Mar-Apr       Impact factor: 4.488

4.  Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects.

Authors:  Weibo Cai; Dong-Woon Shin; Kai Chen; Olivier Gheysens; Qizhen Cao; Shan X Wang; Sanjiv S Gambhir; Xiaoyuan Chen
Journal:  Nano Lett       Date:  2006-04       Impact factor: 11.189

5.  Inorganic nanoparticles for multimodal molecular imaging.

Authors:  Magdalena Swierczewska; Seulki Lee; Xiaoyuan Chen
Journal:  Mol Imaging       Date:  2011-02       Impact factor: 4.488

Review 6.  Nanoparticle-based theranostic agents.

Authors:  Jin Xie; Seulki Lee; Xiaoyuan Chen
Journal:  Adv Drug Deliv Rev       Date:  2010-08-04       Impact factor: 15.470

7.  (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.

Authors:  Zi-Bo Li; Weibo Cai; Qizhen Cao; Kai Chen; Zhanhong Wu; Lina He; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2007-06-15       Impact factor: 10.057

8.  Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting.

Authors:  Kai Chen; Jin Xie; Hengyi Xu; Deepak Behera; Mark H Michalski; Sandip Biswal; Andrew Wang; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2009-09-20       Impact factor: 12.479

9.  Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin alpha(v)beta3-rich tumor cells.

Authors:  Jin Xie; Kai Chen; Ha-Young Lee; Chenjie Xu; Andrew R Hsu; Sheng Peng; Xiaoyuan Chen; Shouheng Sun
Journal:  J Am Chem Soc       Date:  2008-05-24       Impact factor: 15.419

Review 10.  Multifunctional micellar nanomedicine for cancer therapy.

Authors:  Elvin Blanco; Chase W Kessinger; Baran D Sumer; Jinming Gao
Journal:  Exp Biol Med (Maywood)       Date:  2008-12-08
View more
  97 in total

Review 1.  Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives.

Authors:  Ki Young Choi; Gang Liu; Seulki Lee; Xiaoyuan Chen
Journal:  Nanoscale       Date:  2011-12-01       Impact factor: 7.790

2.  Fabrication of magnetic nanoparticles with controllable drug loading and release through a simple assembly approach.

Authors:  Chen Fang; Forrest M Kievit; Omid Veiseh; Zachary R Stephen; Tingzhong Wang; Donghoon Lee; Richard G Ellenbogen; Miqin Zhang
Journal:  J Control Release       Date:  2012-06-24       Impact factor: 9.776

3.  HSA coated iron oxide nanoparticles as drug delivery vehicles for cancer therapy.

Authors:  Qimeng Quan; Jin Xie; Haokao Gao; Min Yang; Fan Zhang; Gang Liu; Xin Lin; Andrew Wang; Henry S Eden; Seulki Lee; Guixiang Zhang; Xiaoyuan Chen
Journal:  Mol Pharm       Date:  2011-08-22       Impact factor: 4.939

4.  Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma.

Authors:  Lihong Bu; Jin Xie; Kai Chen; Jing Huang; Zoraida P Aguilar; Andrew Wang; Kin Wai Sun; Mei-Sze Chua; Samuel So; Zhen Cheng; Henry S Eden; Baozhong Shen; Xiaoyuan Chen
Journal:  Contrast Media Mol Imaging       Date:  2012 Jul-Aug       Impact factor: 3.161

5.  Multifunctional plasmonic shell-magnetic core nanoparticles for targeted diagnostics, isolation, and photothermal destruction of tumor cells.

Authors:  Zhen Fan; Melanie Shelton; Anant Kumar Singh; Dulal Senapati; Sadia Afrin Khan; Paresh Chandra Ray
Journal:  ACS Nano       Date:  2012-01-30       Impact factor: 15.881

6.  Long-circulating heparin-functionalized magnetic nanoparticles for potential application as a protein drug delivery platform.

Authors:  Jian Zhang; Meong Cheol Shin; Allan E David; Jie Zhou; Kyuri Lee; Huining He; Victor C Yang
Journal:  Mol Pharm       Date:  2013-09-11       Impact factor: 4.939

Review 7.  Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.

Authors:  Howard E Gendelman; Vellareddy Anantharam; Tatiana Bronich; Shivani Ghaisas; Huajun Jin; Anumantha G Kanthasamy; Xinming Liu; JoEllyn McMillan; R Lee Mosley; Balaji Narasimhan; Surya K Mallapragada
Journal:  Nanomedicine       Date:  2015-01-31       Impact factor: 5.307

8.  Inorganic Nanoparticles for Therapeutic Delivery: Trials, Tribulations and Promise.

Authors:  Gulen Yesilbag Tonga; Daniel F Moyano; Chang Soo Kim; Vincent M Rotello
Journal:  Curr Opin Colloid Interface Sci       Date:  2014-04-01       Impact factor: 6.448

9.  Mesenchymal stem cell-based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery.

Authors:  Xinglu Huang; Fan Zhang; Hui Wang; Gang Niu; Ki Young Choi; Magdalena Swierczewska; Guofeng Zhang; Haokao Gao; Zhe Wang; Lei Zhu; Hak Soo Choi; Seulki Lee; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2012-12-08       Impact factor: 12.479

10.  Photosensitizer-conjugated silica-coated gold nanoclusters for fluorescence imaging-guided photodynamic therapy.

Authors:  Peng Huang; Jing Lin; Shouju Wang; Zhijun Zhou; Zhiming Li; Zhe Wang; Chunlei Zhang; Xuyi Yue; Gang Niu; Min Yang; Daxiang Cui; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2013-03-22       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.